References
- Aberturas MR, Molpeceres J, Guzman M, Garcia F. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. Journal of Microencapsulation 2002; 19: 61–72
- Allemann E, Gurny R, Leroux JC. Boidegradable nanoparticles of poly(lactic-co-glycolic acid) for parenteral administration. Pharmaceutical dosage forms: Disperse systems, HA Liberman, MM Reiger, GS Banker. Marcel Dekker, New York 1996; 163–194
- Baichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Development and Industrial Pharmacy 1999; 25: 471–476
- Birnbaum DT, Kosmala JD, Brannon-Peppas L. Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles. Journal of Nanoparticle Research 2000; 2: 173–181
- Bodmeier R, McGinity JW. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology. Journal of Microencapsulation 1987a; 4: 279–288
- Cappel MJJK. Effect of nanoparticles on transdermal drug delivery. Journal of Microencapsulation 1991; 8: 369–374
- Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release 2002a; 83: 389–400
- Chorny M, Fishbein I, Danenberg HD, Golomb G. Study of the drug release mechanism from tyrphostin AG-1295 loaded nanospheres by in situ and external sink methods. Journal of Controlled Release 2002b; 83: 401–414
- Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsules formulation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics 1989; 55: R1–R4
- Gaspar MMBD, Cruz MEM, Alonso MJ. Formulation of L-asparaginase-loaded poly(lactic-co-glycolide) nanoparticles: Influence of polymer properties on enzyme loading, acitvity and in vitro release. Journal of Controlled Release 1998; 52: 53–62
- Jain R, Shah NH, Malick AW, Rhodes CT. Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches. Drug Development and Industrial Pharmacy 1998; 24: 703–727
- Lam XMDET, Daugherty AL, Levin N, Cleland JL. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. Journal of Controlled Release 2000; 67: 281–292
- Nagata STK, Hirano K, Takagishi Y. Pharmaceutical dosage form design of copoly (lactic/glycolic acid) microspheres. Mechanism of in vitro release of gentamicin. Yakugaku Zasshi 1994; 114: 1005–1014
- Quintanar-Guerrero D, Allemann E, Doelker E, Fessi H. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharmaceutical Research 1998; 15: 1056–1062
- Siegel SJKIW, Gur RE, Lenox RH, Bilker WB, Ikeda D, Gandhi N, Zhang W-X. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology 2002; 26: 817–823
- Soppimath KS, Aminabhavi TM. Ethyl acetate as a dispersing solvent in the production of poly(dl-lactide-co-glycolide) microspheres: Effect of process parameters and polymer type. Journal of Microencapsulation 2002; 19: 281–292
- Takada SOY. Design and development of controlled release of drugs from injectable microcapsules. Nippon Rinsho 1998; 56: 675–679